In ALK fusion‐positive NSCLC, novel variant ALK fusions (e.g., non–EML4‐ALK fusions) are increasingly being identified alongside the canonical EML4‐ALK fusion [10]. Here, EML4 is linked to non-small cell lung carcinoma.